A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Acitretin


Stiefel Laboratories Moves to Solidify, Enhance Its Leadership ...  -  Apr 23, 2007
PR Newswire (press release),0.12%; MimyX(TM) Cream; Olux(R) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules;

Stiefel Laboratories Moves to Solidify, Enhance Its Leadership ...  -  Apr 23, 2007
PharmaLive.com (press release),0.12%; MimyX(TM) Cream; Olux(R) (clobetasol propionate) Foam, 0.05%; Olux-E(TM) (clobetasol propionate) Foam, 0.05%; Soriatane(R) (acitretin) capsules;

New psoriasis treatmentsmay help when others fail  -  Feb 5, 2007
SouthCoastToday.com,For more extensive skin involvement, oral medicines such as methotrexate and Acitretin can often control outbreaks. The latest treatments are medicines

ADIPEX , adipex phentermine vs , adipex prescription , adipex diet ...  -  Dec 27, 2006
Indymedia Colombia,Each tablet of University of adipex reach of adipex on. adipex not share your acitretin prescription with anyone else. . Recommended dosage ADULTS Adipex-P

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Genetic Engineering News (press release),The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin)

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Business Wire (press release),The Company's marketed products are OLUX ® (clobetasol propionate) Foam, 0.05%; Luxíq ® (betamethasone valerate) Foam, 0.12%; Soriatane ® (acitretin)

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Genetic Engineering News (press release),The Company's marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin)

Connetics Announces Results of Special Stockholders Meeting  -  Dec 20, 2006
Business Wire (press release),The Company's marketed products are OLUX ® (clobetasol propionate) Foam, 0.05%; Luxíq ® (betamethasone valerate) Foam, 0.12%; Soriatane ® (acitretin)

Guideline on Collecting Blood Strengthened  09 Nov 2006
According to the ministry, those who take acitretin, used to treat severe psoriasis, or methotrexate, life-threatening cancer treatment, or who are injected ... -Korea Times, Connetics Launches Verdeso Foam for the Treatment of Mild-to ...  09 Nov 2006
...commercial products are OLUX (clobetasol propionate) Foam, 0.05%; Luxiq (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; Evoclin(R ... -PharmaLive.com (press release), No need to fear it  Oct 28, 2006
Systemic retinoid therapy uses a promising drug called acitretin now, but this should be used carefully in women of childbearing age. ... -Hindu, Connetics Corporation to Merge into Stiefel Laboratories  Oct 23, 2006
...commercial products are OLUX® (clobetasol propionate) Foam, 0.05%; Luxiq® (betamethasone valerate) Foam, 0.12%; Soriatane® (acitretin) capsules; Evoclin ... -Yahoo! News (press release) Red Cross at fault over tainted blood donations  Sep 6, 2006
Jeon Jae-hee of the Grand National Party said 3,980 people received blood from donors who were being treated with the drug Acitretin, which is known to cause ... -Korea Herald (subscription)

Fear of Tainted Blood  Sep 7, 2006
This time, as many as 4,000 patients received blood from donors who took Acitretin, a drug used to treat psoriasis, which has been known to cause birth defects ... -Korea Times

FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to ...  Sep 20, 2006
...commercial products are OLUX (clobetasol propionate) Foam, 0.05%; Luxiq (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; Evoclin ... -PharmaLive.com

Possibly tainted blood used in 4,000 cases: report  Sep 6, 2006
The blood had come from donors that had taken acitretin, a form of vitamin A used to treat psoriasis and other skin ailments. The ... -The Hankyoreh

Tainted Blood Used for Transfusion: Report  Sep 6, 2006
...from the National Red Cross of Korea, about 3,930 patients received blood supplies from donors who took the psoriasis treatment medicine, acitretin, from 2003. ... -Korea Times

Connetics Reports Positive Results From Second Phase III Clinical ...  Aug 28, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and Evoclin ... -Genetic Engineering News

New Rogaine(R) Foam Features Connetics' Proprietary VersaFoam(R) ...  Sep 5, 2006
Company's marketed products are OLUX (clobetasol propionate) Foam, 0.05%; Luxiq (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and ... -Business Wire

Connetics Announces Special Meeting of Stockholders to Approve ...  -  Nov 17, 2006
Business Wire (press release),The Company's marketed products are OLUX ® (clobetasol propionate) Foam, 0.05%; Luxíq ® (betamethasone valerate) Foam, 0.12%; Soriatane ® (acitretin)

Connetics Reports Positive Results From Second Phase III Clinical ...  29 Aug 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and Evoclin ... -Business Wire

Connetics Reports New Option Grants Under Nasdaq Marketplace Rule ...  Aug 7, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) capsules and Evoclin ... -Business Wire

Connetics Announces Extension and Changes in Terms of Convertible ...  Jul 19, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and Evoclin ... -Business Wire



Connetics Reports Preliminary Results for First Quarter 2006 ...  May 3, 2006
...a Citizen Petition to the US Food and Drug Administration (FDA) requesting that any generic products that reference Soriatane (acitretin) meet several criteria ... - PharmaLive.com

Connetics Names Sunil Patel Vice President, Corporate Development ...  May 9, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) capsules and Evoclin ... - PharmaLive.com





Connetics Files Citizen Petition for Soriatane With the FDA ...  Apr 3, 2006
...of a Citizen Petition with the US Food and Drug Administration (FDA) to request that any generic products that reference Soriatane(R) (acitretin) meet several ... - Genetic Engineering News

Connetics Says It Has Filed Citizen Petition For Soriatane With ...  Apr 3, 2006
...to the company, the criteria outlined in the Citizen Petition will ensure that patients are adequately protected from generic versions of acitretin that might ... - Trading Markets

Connetics Provides Information on Securities and Exchange ...  Apr 7, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%; Luxiq(R) (betamethasone valerate) Foam, 0.12%; Soriatane(R) (acitretin) capsules; and Evoclin ... - PharmaLive.com

TODAY ON PHARMALIVE.COM  Mar 2, 2006
Connetics will sponsor a poster featuring Soriatane(R) (acitretin) that highlights the safety and efficacy of low-dose acitretin in the treatment of moderate ... - PharmaLive.com,

March of Dimes Applauds FDA Monitoring Program  Feb 9, 2006
The organization's comments came in a national policy statement on retinoid drugs such as Accutane and the psoriasis medication Soriatane (acitretin). ... - PR Newswire,

March of Dimes Applauds FDA Monitoring Program  09 Feb 2006
The organization's comments came in a national policy statement on retinoid drugs such as Accutane and the psoriasis medication Soriatane (acitretin). ... - PR Newswire

Connetics Names Freddie Park Vice President, Intellectual Property ...  Feb 6, 2006
...marketed products are OLUX(R) (clobetasol propionate) Foam, 0.05%, Luxiq(R) (betamethasone valerate) Foam, 0.12%, Soriatane(R) (acitretin) capsules and Evoclin ... - Genetic Engineering News


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional